{"id":532744,"date":"2021-08-31T08:33:16","date_gmt":"2021-08-31T12:33:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/"},"modified":"2021-08-31T08:33:16","modified_gmt":"2021-08-31T12:33:16","slug":"longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/","title":{"rendered":"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Aug.  31, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dcpNX0o40iCcgLPiFo4wLM8l9ufqIakhA-ELFUtL4uF2-zXY2cZtjvMIxKOk3j1056v4icnpkR2-AiCuixebiIQPYIeeNMWsvxSfpRco5eAg3JJYiJDhJUA_dglBgVVC\" rel=\"nofollow noopener\" target=\"_blank\">Longboard Pharmaceuticals, Inc.<\/a> (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin R. Lind, Longboard\u2019s President &amp; Chief Executive Officer, will present virtually in a fireside chat format at two upcoming investor conferences: Citi\u2019s 16th Annual BioPharma Virtual Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference.<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Citi\u2019s BioPharma Conference:<\/strong> Wednesday, September 8, 2021, at 3:15 PM ET<\/li>\n<li style=\"text-align:justify\">\n          <strong>H.C. Wainwright\u2019s Global Investment Conference:<\/strong> Webcast available beginning Monday, September 13, 2021, at 7:00 AM ET<\/li>\n<\/ul>\n<p align=\"justify\">To access live webcasts of Longboard\u2019s presentations, please visit the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JqUZs8IC7JSPItrddBUbu1zvtvhq2O1CDd3S3KXB2bPo3P-gxSklwtOVOes0NVfohSFu4qyB4mpGF9BfwA6KwIwS8L5-3IO0T1oMmamF9jKOs10nSmQ_O97iJJfW3BY0DEMiGjJjBlQN82icqtIv97htziyY4BJwmuEB3L1_xbM=\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d page within the Investors Relations section of Longboard\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=srdjXWYWBDYZYBqQN0hFKazggVzwUWBAsmOaz7fDNppoDDJYTt6phI1wc1OZnSg_evAXEKlJZQoN1FT-vAzLF80mvYk0Dj26jfR2CG5uhpWNGYJr5biDva18oWpFXP2h\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.longboardpharma.com\/<\/a>. Replays of the webcasts will be available shortly after the completion of the events and archived on the website for at least 30 days.<\/p>\n<p align=\"justify\">\n        <strong>About Longboard Pharmaceuticals <\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dcpNX0o40iCcgLPiFo4wLM8l9ufqIakhA-ELFUtL4uEn-5fpwyZHDdV1JYJjqTNm5GijyapHt0egACcq-ZsuZMN__3XYJIH8VbDJEPaxhiO0X1X6KElSAw66jjvo6L5D\" rel=\"nofollow noopener\" target=\"_blank\">Longboard Pharmaceuticals, Inc.<\/a> is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard was formed in January 2020 by Arena Pharmaceuticals, Inc. (Arena) to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Longboard\u2019s small molecule <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CDA06bykaPM4-EkdcKv0eLaOzuRJbrgvR8B2fXLr5FePfl6ZYe4XgmPfIObut27bmVqfkW2YA3vxrF73bcUrhwA7FN8t3TtLx0N-YaMR0xXtw71-5eGpqRip0tJJgG8R\" rel=\"nofollow noopener\" target=\"_blank\">product candidates<\/a> were discovered out of the same platform at Arena that represents a culmination of more than 20 years of GPCR research. Longboard is evaluating LP352, an oral, centrally acting, 5-hydroxytryptamine 2c receptor subtype superagonist, with negligible observed impact on 5-HT2b and 5-HT2a receptor subtypes, in development for the potential treatment of developmental and epileptic encephalopathies. Longboard is also evaluating LP143, a centrally acting, full cannabinoid type 2 receptor agonist, in development for the potential treatment of neurodegenerative diseases associated with neuroinflammation caused by microglial activation, and LP659, a centrally acting, sphingosine-1-phosphate receptor subtypes 1 and 5 modulator, in development for the potential treatment of central nervous system neuroinflammatory diseases.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Longboard\u2019s participation in the upcoming conferences, clinical and preclinical programs, ability to develop medicines, and focus. For such statements, Longboard claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Longboard\u2019s expectations. Factors that could cause actual results to differ materially from those stated or implied by Longboard\u2019s forward-looking statements are disclosed in Longboard\u2019s filings with the Securities and Exchange Commission (SEC). These forward-looking statements represent Longboard\u2019s judgment as of the time of this release. Longboard disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDI5MDY3Y2YtMmQyMC00MjMyLTlkODAtYTBhMDA4ZmNhNTg1LTEyMTc4MjM=\/tiny\/Longboard-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Corporate Contact:\r\nMegan E. Knight\r\nHead of Investor Relations \r\nmknight@longboardpharma.com\r\nIR@longboardpharma.com\r\n619.592.9775<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) &#8212; Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin R. Lind, Longboard\u2019s President &amp; Chief Executive Officer, will present virtually in a fireside chat format at two upcoming investor conferences: Citi\u2019s 16th Annual BioPharma Virtual Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference. Citi\u2019s BioPharma Conference: Wednesday, September 8, 2021, at 3:15 PM ET H.C. Wainwright\u2019s Global Investment Conference: Webcast available beginning Monday, September 13, 2021, at 7:00 AM ET To access live webcasts of Longboard\u2019s presentations, please visit the \u201cEvents &amp; Presentations\u201d page within the Investors Relations section of Longboard\u2019s website at https:\/\/ir.longboardpharma.com\/. Replays of the webcasts &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-532744","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) &#8212; Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin R. Lind, Longboard\u2019s President &amp; Chief Executive Officer, will present virtually in a fireside chat format at two upcoming investor conferences: Citi\u2019s 16th Annual BioPharma Virtual Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference. Citi\u2019s BioPharma Conference: Wednesday, September 8, 2021, at 3:15 PM ET H.C. Wainwright\u2019s Global Investment Conference: Webcast available beginning Monday, September 13, 2021, at 7:00 AM ET To access live webcasts of Longboard\u2019s presentations, please visit the \u201cEvents &amp; Presentations\u201d page within the Investors Relations section of Longboard\u2019s website at https:\/\/ir.longboardpharma.com\/. Replays of the webcasts &hellip; Continue reading &quot;Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-31T12:33:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences\",\"datePublished\":\"2021-08-31T12:33:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/\"},\"wordCount\":450,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/\",\"name\":\"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=\",\"datePublished\":\"2021-08-31T12:33:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) &#8212; Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin R. Lind, Longboard\u2019s President &amp; Chief Executive Officer, will present virtually in a fireside chat format at two upcoming investor conferences: Citi\u2019s 16th Annual BioPharma Virtual Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference. Citi\u2019s BioPharma Conference: Wednesday, September 8, 2021, at 3:15 PM ET H.C. Wainwright\u2019s Global Investment Conference: Webcast available beginning Monday, September 13, 2021, at 7:00 AM ET To access live webcasts of Longboard\u2019s presentations, please visit the \u201cEvents &amp; Presentations\u201d page within the Investors Relations section of Longboard\u2019s website at https:\/\/ir.longboardpharma.com\/. Replays of the webcasts &hellip; Continue reading \"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-31T12:33:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences","datePublished":"2021-08-31T12:33:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/"},"wordCount":450,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/","name":"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=","datePublished":"2021-08-31T12:33:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUzOCM0MzgxNTQ3IzIyMDYyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-present-at-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/532744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=532744"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/532744\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=532744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=532744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=532744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}